242 related articles for article (PubMed ID: 16566861)
1. Cytokine and anti-cytokine therapy for asthma.
Simon HU
Curr Allergy Asthma Rep; 2006 Mar; 6(2):117-21. PubMed ID: 16566861
[TBL] [Abstract][Full Text] [Related]
2. Advanced Molecular Knowledge of Therapeutic Drugs and Natural Products Focusing on Inflammatory Cytokines in Asthma.
Lin SC; Shi LS; Ye YL
Cells; 2019 Jul; 8(7):. PubMed ID: 31284537
[TBL] [Abstract][Full Text] [Related]
3. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and cytokine-specific therapy in asthma.
Desai D; Brightling C
Adv Clin Chem; 2012; 57():57-97. PubMed ID: 22870587
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for asthma.
Walsh GM
Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-directed therapy in asthma.
Ichinose M; Barnes PJ
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):263-9. PubMed ID: 15379594
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
[TBL] [Abstract][Full Text] [Related]
8. The Cytokines of Asthma.
Lambrecht BN; Hammad H; Fahy JV
Immunity; 2019 Apr; 50(4):975-991. PubMed ID: 30995510
[TBL] [Abstract][Full Text] [Related]
9. Recent Patents for the Treatment of Asthma.
El-Qutob D; Raducan I
Recent Pat Inflamm Allergy Drug Discov; 2016; 10(1):13-20. PubMed ID: 27262358
[TBL] [Abstract][Full Text] [Related]
10. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.
Herbert C; Hettiaratchi A; Webb DC; Thomas PS; Foster PS; Kumar RK
Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529
[TBL] [Abstract][Full Text] [Related]
11. Knowledge of inflammatory cytokines and mediators in asthma: what is its importance in clinical practice?
Nardini S
Monaldi Arch Chest Dis; 1997 Feb; 52(1):86-8. PubMed ID: 9151532
[No Abstract] [Full Text] [Related]
12. [Targeted asthma therapies: confirmations, hopes, and disappointments].
Schleich F; Louis R
Rev Med Liege; 2012; 67 Spec No():14-21. PubMed ID: 22690481
[TBL] [Abstract][Full Text] [Related]
13. Inflammation, inflammatory mediators, and mediator antagonists in asthma.
Lazarus SC
J Clin Pharmacol; 1998 Jul; 38(7):577-82. PubMed ID: 9702841
[TBL] [Abstract][Full Text] [Related]
14. Future biologic therapies in asthma.
Quirce S; Bobolea I; Domínguez-Ortega J; Barranco P
Arch Bronconeumol; 2014 Aug; 50(8):355-61. PubMed ID: 24685200
[TBL] [Abstract][Full Text] [Related]
15. [Research on inflammatory mediators in asthma: new therapeutic approaches].
Magnan A; Molimard M; Braunstein G; Devillier P
Therapie; 1999; 54(4):447-61. PubMed ID: 10667111
[TBL] [Abstract][Full Text] [Related]
16. Emerging Biologics in Severe Asthma.
Pavord ID; Hilvering B; Shrimanker R
Immunol Allergy Clin North Am; 2016 Aug; 36(3):609-23. PubMed ID: 27401629
[TBL] [Abstract][Full Text] [Related]
17. Cytokine antagonists for the treatment of asthma: progress to date.
Antoniu SA
BioDrugs; 2009; 23(4):241-51. PubMed ID: 19697966
[TBL] [Abstract][Full Text] [Related]
18. [The future of asthma therapy].
Solèr M
Schweiz Med Wochenschr; 2000 Feb; 130(8):277-81. PubMed ID: 10726286
[TBL] [Abstract][Full Text] [Related]
19. Targeting interleukins to treat severe asthma.
Gibeon D; Menzies-Gow AN
Expert Rev Respir Med; 2012 Aug; 6(4):423-39. PubMed ID: 22971067
[TBL] [Abstract][Full Text] [Related]
20. Novel therapies for the treatment of inflammatory airway disease.
Hele DJ; Belvisi MG
Expert Opin Investig Drugs; 2003 Jan; 12(1):5-18. PubMed ID: 12517250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
